Приказ основних података о документу
Anti-melanoma effects of ingenanes isolated from Euphorbia species
dc.creator | Krstić, Gordana | |
dc.creator | Jadranin, Milka | |
dc.creator | Jovanović Stojanov, Sofija | |
dc.creator | Pešić, Milica | |
dc.creator | Tešević, Vele | |
dc.creator | Milosavljević, Slobodan | |
dc.date.accessioned | 2024-03-19T07:47:26Z | |
dc.date.available | 2024-03-19T07:47:26Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 1409 - 8695 | |
dc.identifier.uri | http://radar.ibiss.bg.ac.rs/handle/123456789/6594 | |
dc.description.abstract | In this research, from two species, E. palustris and E. lucida, four ingenane derivatives were isolated. Their anticancer effects were evaluated in the human melanoma – 518A2 cell line and compared with the effects of ingenolmebutate. Selectivity towards human melanoma cells was determined using normal human keratinocytes – HaCaT. | sr |
dc.language.iso | en | sr |
dc.publisher | Skopje: Macedonian Pharmaceutical Association | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200168/RS// | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200026/RS// | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200007/RS// | sr |
dc.rights | openAccess | sr |
dc.source | 11th Conference on Medicinal and Aromatic Plants of Southeast European Countries 2022: CMAPSEEC 2022; 2022 Oct 6-10; Ohrid, Republic of North Macedonia | sr |
dc.subject | anticancer | sr |
dc.subject | isolation | sr |
dc.subject | plants | sr |
dc.title | Anti-melanoma effects of ingenanes isolated from Euphorbia species | sr |
dc.type | conferenceObject | sr |
dc.rights.license | ARR | sr |
dc.rights.holder | © 2023 North-Western Journal of Zoology University of Oradea | sr |
dc.description.other | 11th Conference on Medicinal and Aromatic Plants of Southeast European Countries 2022: CMAPSEEC 2022; 2022 Oct 6-10; Ohrid, Republic of North Macedonia. Skopje: Macedonian Pharmaceutical Association, 2022. p. 23-4. (Macedonian Pharmaceutical Bulletin; Vol. 68. Suppl. 2). | sr |
dc.identifier.doi | 10.33320/maced.pharm.bull.2022.68.04.006 | |
dc.citation.spage | 23 | |
dc.citation.epage | 24 | |
dc.type.version | publishedVersion | sr |
dc.identifier.fulltext | https://radar.ibiss.bg.ac.rs/bitstream/id/17112/file-Sofija.pdf | |
dc.citation.rank | M33 |